US 11596633
SHP2 inhibitor compositions and methods for treating cancer
granted A61KA61K31/282A61K31/4427
Quick answer
US patent 11596633 (SHP2 inhibitor compositions and methods for treating cancer) held by Revolution Medicines, Inc. expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Revolution Medicines, Inc.
- Grant date
- Tue Mar 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/282, A61K31/4427, A61K31/4439, A61K31/497